US DOJ Launches WHIP Whistleblower Programme Offering Up to $30,000 for Fraud Tips
The United States Department of Justice (DOJ) has launched the Fraud Whistleblower Incentive Program (WHIP), a new initiative designed to encourage individuals to report suspected fraud by offering...
The United States Department of Justice (DOJ) has launched the Fraud Whistleblower Incentive Program (WHIP), a new initiative designed to encourage individuals to report suspected fraud by offering discretionary monetary rewards of between $10,000 and $30,000 for qualifying information that leads to criminal charges.
Announced on 20 October 2026 by the DOJ and its National Fraud Enforcement Division, the programme introduces an early-stage reward mechanism intended to encourage the prompt disclosure of credible information about specified categories of fraud. The US Department of the Treasury has committed $25 million to support its implementation.
Unlike many established government whistleblower schemes, which generally determine payments after a case reaches a later enforcement or recovery stage, WHIP is designed to provide eligible tipsters with an opportunity to receive an award at or around the filing of criminal charges. The programme does not require the case to result in substantial fines or asset forfeiture before an early-stage award can be considered.
However, payment is not automatic. The DOJ retains discretion over eligibility and award amounts, and a qualifying submission must satisfy the programme’s requirements.
Scope of the Programme
The programme covers information relating to federal healthcare offences and associated crimes, as well as fraud involving specified government programmes and benefits administered by federal agencies. These include the Departments of Agriculture, Labor, Health and Human Services, Housing and Urban Development, Education, Veterans Affairs and War, alongside the Small Business Administration.
Within healthcare, the DOJ has identified hospice services, home healthcare, daycare and special-services fraud as particular priorities. Potential cases may involve fraudulent claims, illegal kickbacks, bribes, medically unnecessary services or services that were never provided as represented.
Although healthcare fraud and public-benefit fraud are central to the programme, its published terms do not expressly identify international trade fraud or tax-revenue fraud as standalone qualifying categories. Organisations should therefore consult the official eligibility criteria before assuming that a particular allegation falls within WHIP.
Eligibility and Reporting Requirements
WHIP is intended for individuals who voluntarily submit truthful, complete and original information in writing and cooperate fully with the DOJ. The information must be sufficiently specific, credible and timely to contribute to the opening or reopening of an investigation, or to the investigation of additional conduct, and ultimately lead to criminal charges within an eligible subject area.
Individuals who meaningfully participated in the underlying misconduct are generally ineligible, subject to limited exceptions at the DOJ’s discretion. Companies and other entities cannot themselves qualify as whistleblowers under the programme, although individuals with relevant information may be eligible if they satisfy the applicable conditions.
Anonymous submissions are permitted through an attorney, subject to the programme’s procedures. A whistleblower’s identity must ultimately be disclosed and verified before an award can be paid. The DOJ also retains discretion over whether to grant an award and the amount payable.
Official programme information and reporting instructions are available through the DOJ’s WHIP programme page and its designated fraud reporting portal.
Compliance and Financial Crime Implications
Corporate Fraud Detection
The introduction of WHIP reinforces the importance of effective internal reporting channels and controls capable of identifying suspected fraud before it escalates into a criminal investigation.
Organisations operating in healthcare, public procurement, government-funded services and federal benefit programmes should review their fraud-risk assessments, internal escalation procedures and investigation protocols. Particular attention should be given to billing integrity, vendor relationships, procurement decisions, conflicts of interest and payments that lack a clear commercial justification.
Anti-Money Laundering and Counter-Terrorist Financing
WHIP is a fraud-reporting and enforcement initiative, not a standalone anti-money laundering or counter-terrorist financing regime. Nevertheless, the underlying fraud identified through whistleblower disclosures may generate proceeds that require further financial investigation.
Where evidence indicates that suspected fraud proceeds have been transferred, concealed or integrated into the financial system, compliance teams should assess the relevant money-laundering risks and reporting obligations under applicable law. The existence of a whistleblower allegation alone does not establish that money laundering or terrorist financing has occurred.
Third-Party and Transaction Monitoring
Fraud risks may arise through intermediaries, suppliers, healthcare providers, contractors and other third parties. Organisations should maintain appropriate due diligence, verify the legitimacy of services and invoices, monitor unusual payment patterns and investigate discrepancies between contractual terms and actual activity.
Controls should also provide a documented process for handling whistleblower allegations, preserving relevant records, escalating credible concerns and protecting the integrity of internal investigations.
Whistleblower Protection and Retaliation Risk
The programme’s requirements make it important for organisations to avoid obstructing employees or other individuals who seek to report potential criminal conduct to the authorities. The DOJ states that retaliation and attempts to impede direct communication with the Department may be considered when assessing corporate cooperation, compliance programmes and potential obstruction.
Businesses should review confidentiality provisions, reporting policies and investigation procedures to ensure that legitimate reporting is not improperly restricted. Legal counsel should be involved where questions arise concerning employee protections, privilege, confidentiality or regulatory disclosure obligations.
Implications for Compliance Officers and Corporate Boards
The programme creates an additional incentive for individuals to disclose original information about eligible fraud directly to federal authorities. For compliance officers, this increases the importance of ensuring that internal reporting mechanisms are accessible, credible and capable of addressing complaints promptly.
Corporate boards and senior management should consider whether their existing controls provide sufficient assurance that allegations are investigated independently, evidence is preserved and appropriate corrective action is taken. A well-designed compliance programme should be capable of identifying and addressing misconduct without depending solely on external whistleblower disclosures.
At the same time, organisations should avoid treating every whistleblower complaint as proof of criminal activity. Allegations require a proportionate, evidence-based investigation, and any decision to report suspected misconduct or pursue disciplinary action should follow applicable law and established procedures.
The launch of WHIP marks a significant development in the DOJ’s approach to encouraging the early reporting of specified categories of fraud. By offering discretionary awards at the criminal-charging stage, the programme seeks to motivate individuals with credible information to assist federal investigations without requiring them to wait for the conclusion of lengthy enforcement proceedings.
For compliance, fraud and AML/CFT professionals, the development highlights the importance of strong internal reporting channels, effective transaction monitoring, third-party due diligence and prompt investigation of credible allegations.
The programme’s practical impact will depend on how the DOJ applies its eligibility criteria, evaluates submissions and exercises its discretion over awards. Organisations should monitor official guidance and ensure that their fraud-prevention and whistleblower policies remain aligned with applicable legal obligations.



No Comment! Be the first one.